Peptides/Hormones and growth
Ipamorelin
Also sold as NNC 26-0161
The selective growth hormone releaser popular in anti-ageing circles, well tolerated in studies and known for its effect on sleep.

At a glance
What people use it for
- Sleep quality and recovery
- Lean muscle and body composition
- Marketed as a gentler alternative to growth hormone
How it is taken
Sold as a powder for injection, typically taken before bed, often stacked with CJC-1295.
Evidence
No human trials yet
Best known for
- Selective: little effect on cortisol or prolactin, unlike older compounds
- Developed and tested in humans by a pharmaceutical company
- Deeper sleep is the most consistently reported effect
- Works through the ghrelin receptor rather than the GHRH receptor
Ipamorelin prompts the pituitary to release growth hormone, in a similar spirit to sermorelin but through a different receptor. Its selling point is selectivity: in early studies it raised growth hormone without much effect on cortisol or prolactin, which is what made it interesting compared with older compounds in its family.
It was developed by a pharmaceutical company and tested in people, which puts it ahead of most of its peers on provenance.
Why people are talking about it
Sleep, mostly. It is the effect users report most consistently and the one with the most plausible physiology behind it: the body's largest natural growth hormone pulse happens in slow-wave sleep, and ipamorelin is usually taken at night to sit alongside it.

Selectivity is the other reason. The older compounds in this family raised cortisol and prolactin along with growth hormone, which made them blunt instruments. Ipamorelin was designed to avoid that, and the early data suggests it does.
What people take it for
Sleep, recovery and body composition, usually taken before bed. It is one of the most commonly used peptides in anti-ageing and physique circles.
Sleep
The claim is that sleep becomes deeper and more restorative. The mechanism is that ipamorelin acts at the ghrelin receptor to trigger a growth hormone pulse, and the largest natural pulse occurs in slow-wave sleep.
What that looks like to a person is waking less and feeling more rested. This has not been measured in a controlled sleep study, and the reports come from people usually taking it alongside another compound.
Body composition
The claim is more lean mass and less fat, running through growth hormone and IGF-1, which influence protein synthesis and the mobilisation of stored fat.
Put another way, the pitch is that the body is nudged toward building rather than storing. Early human work confirmed the hormone rise.
A gentler alternative to growth hormone
The claim is the benefits of growth hormone without its problems, because the pituitary is asked rather than bypassed. That difference is real: feedback control stays in play, so the body can still moderate its own output.
What the evidence shows
The pharmacology is genuine and was developed by a real pharmaceutical company. Early human work confirmed it does raise growth hormone, and it did so more selectively than the compounds that came before it.

Development was later discontinued, and no completed trial demonstrates the outcomes people buy it for. Raising growth hormone is a mechanism; whether it translates into something a person notices over months is the question a trial would answer, and that trial was never finished.
Reported effects are mostly mild: injection site reactions, a head rush or flushing shortly after a dose, and occasional water retention. Increased appetite is commonly described, which is unsurprising for a compound acting at the ghrelin receptor.
How it is taken
Protocols circulating online describe subcutaneous injection before bed, often on an empty stomach, and usually alongside CJC-1295. The timing argument is that food, and particularly carbohydrate, blunts a growth hormone pulse.
Those schedules come from vendor documentation and community practice rather than from a trial, and no clinically established dose exists.
How it compares
Against CJC-1295
CJC-1295 works on a different receptor and, in its DAC form, keeps growth hormone raised for days rather than producing a pulse. The two are sold together on the argument that the effects are complementary, which has not been tested against either compound alone.

Because it is nearly always sold stacked, anyone reporting a benefit from the pair has no way to know which half produced it.
Against sermorelin
Sermorelin is a prescription compound with a real regulatory history and a diagnostic use behind it. Ipamorelin has the better selectivity profile and the shorter paper trail.
Common questions
Why was development stopped?
The public record does not give a reason. What is on it is that a company took it into human studies and did not take it further, which is the ordinary fate of most compounds that reach that stage.
Does it raise cortisol?
Early studies suggested it is more selective than older compounds in its family, with little effect on cortisol or prolactin. That was much of why it attracted attention.
Why take it at night?
To line the pulse up with the body's own largest natural release, which happens during deep sleep.
Is it detectable in testing?
Yes. Growth hormone secretagogues are on the prohibited list in tested sport and are screened for.
Last reviewed .